Platform Capital — 2021 Investments
1 investments dated 2021 · listed companies and verified rows first · show all
Konikukoniku.comin𝕏Dec 2021
Koniku develops co-processors built from biological neurons, using DNA sequences to create receptors that enable sensing applications.
BiotechDeep TechHardwareNewark, US
Oshiorenoya E. Agabi(Executive Officer, Director)
BoardJohn Yu(Director)
Co-investorsEvolution VC PartnersFlucas VenturesLoftyInc CapitalSand Hill Angels
Rows marked “SEC filing” are inferred from directors named on the company's SEC Form D — public regulatory data, not a portfolio list published by the firm.